Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Nuclear Medicine Communications|August 7, 2012
Noninvasive parametric blood flow imaging of head and neck tumours using [15O]H2O and PET/CTGaber Komar, Vesa Oikonen, Hannu Sipilä, et al.Molecular Imaging and Biology|April 19, 2007
Voxel-based NK1 receptor occupancy measurements with [(18)F]SPA-RQ and positron emission tomography: a procedure for assessing errors from image reconstruction and physiological modelingEsa Wallius, Mikko Nyman, Vesa Oikonen, et al.Metabolism: Clinical and Experimental|December 24, 2022
Evaluation of renal glucose uptake with [<sup>18</sup>F]FDG-PET: Methodological advancements and metabolic outcomesEleni Rebelos, Andrea Mari, Vesa Oikonen, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 11, 2006
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference regionJussi Hirvonen, Jaana Kajander, Topias Allonen, et al.Metabolites|February 23, 2024
Kinetic Modeling of Brain [<sup>18-</sup>F]FDG Positron Emission Tomography Time Activity Curves with Input Function Recovery (IR) MethodMarco Bucci, Eleni Rebelos, Vesa Oikonen, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratioKaisa Lehtiö, Vesa Oikonen, Samuel Nyman, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2011
Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairmentJere R Virta, Sari Laatu, Riitta Parkkola, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studiesTuula Tolvanen, Kaisa Lehtiö, Jarmo Kulmala, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomographyAnne Roivainen, Kjell Någren, Jussi Hirvonen, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2006
Simultaneous evaluation of myocardial blood flow, cardiac function and lung water content using [15O]H2O and positron emission tomographyAlexandru Naum, Helena Tuunanen, Erik Engblom, et al.Pageof 11